Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

@article{Beck2017ContinuousGM,
  title={Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.},
  author={Roy W Beck and Tonya D Riddlesworth and Katrina J. Ruedy and Andrew A Ahmann and Stacie K Haller and D. Kruger and Janet B. McGill and William H Polonsky and David Price and Stephen L. Aronoff and Ronnie Aronson and Elena Toschi and Craig R. Kollman and Richard M Bergenstal},
  journal={Annals of internal medicine},
  year={2017},
  volume={167 6},
  pages={365-374}
}
Background Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials.gov: NCT02282397… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 82 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose

  • M Pazos-Couselo, JM Garcı́a-López, M González-Rodrı́guez, F Gude, JM Mayán-Santos, S Rodrı́guez-Segade
  • Observational prospective study. Can J Diabetes
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…